Tristel EBIT per Share
The EBIT per Share of Tristel (TSTL.L) as of Aug 9, 2026 is 0.20 GBP. In the previous year, EBIT per Share was 0.15 GBP — a change of 37.89% (higher).
Get this data via API
Financial Data API
EBIT per Share
0.20GBP
YoY
37.89%
Last updated:
EBIT per Share of Tristel is 2026 0.20 GBP. EBIT per Share of Tristel was 2025 0.15 GBP. It decreases by 37.89% higher compared to the previous year.
Access this data via the Eulerpool API
Tristel Stock analysis
What does Tristel do? Tristel PLC is a British company that specializes in the manufacturing of disinfectants and hygiene products. It was founded in 1993 in Newmarket and is headquartered in Snailwell, Cambridgeshire. Tristel PLC is a publicly traded company listed on the London Stock Exchange. The company's history began with a patent for a new, patented technology for the disinfection of medical instruments, invented by founder Julie Bingham. Tristel PLC now operates in multiple sectors, including manufacturing products for the disinfection of medical instruments and surfaces, veterinary medicines, and disinfectants for use in food processing and other industries. Its main business units are Tristel Medical, Tristel Manufacturing, and Tristel Solutions. Tristel Medical produces disinfectants used on medical instruments and surfaces, offering a range of products such as Tristel Duo for the disinfection of ultrasound probes, endoscopes, and other medical instruments, as well as the Tristel Sporicidal Wipes System for killing dangerous bacteria and viruses on medical instruments. Tristel Manufacturing specializes in veterinary medicines and specialized hygiene products for use in agricultural farms and veterinary practices. Tristel Solutions provides customized products and solutions tailored to the specific needs and requirements of its customers, working closely with representatives from the medical and animal husbandry fields to develop innovative and customer-specific disinfection products. A key aspect of Tristel PLC's business model is its production of most of its products using water-based formulas, ensuring the provision of environmentally friendly and safe products. The company is committed to continuously improving its products to achieve higher standards in environmental protection. In summary, Tristel PLC is a leading manufacturer of disinfectants and hygiene products. Its history began with an innovative technology for the disinfection of medical instruments and has since expanded into various business sectors. The company offers a wide range of products focusing on medical instruments, animal products, and hygiene solutions in agriculture and other industries. Tristel PLC strives to continually improve its products to achieve the highest standards in environmental friendliness and safety. Tristel is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Tristel stock
EBIT per Share of Tristel is 0.20 GBP in 2026.
EBIT per Share of Tristel changed from 0.15 GBP to 0.20 GBP, representing a 37.89% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Tristel since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Tristel
All Key Metrics — Tristel
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth